Chinese oncology developers including BeiGene, Ltd., Jiangsu Hengrui Medicine Co., Ltd. and Shanghai Junshi Biosciences Co., Ltd. all released new clinical data during the recent European Society for Medical Oncology (ESMO) meeting.
Chinese Language Podcast: ESMO China Data, Annual CDE Report, Shanghai Biopharma Week
Regulatory Trends, Latest Data Readouts And More
Topics in this latest Chinese-language podcast include the China Center for Drug Evaluation's annual IND and NDA report, highlights of Chinese companies' data readouts at ESMO, and policy signals from the International Biopharma Industry Week Shanghai.